Cancer Therapy Evaluation Program: Difference between revisions

no edit summary
No edit summary
No edit summary
 
(3 intermediate revisions by one other user not shown)
Line 3: Line 3:
|ProgramType=Program
|ProgramType=Program
|OrgSponsor=National Cancer Institute
|OrgSponsor=National Cancer Institute
|TopOrganization=National Institutes of Health
|CreationLegislation=National Cancer Act of 1971
|CreationLegislation=National Cancer Act of 1971
|Purpose=To facilitate the development of new cancer treatments by coordinating and funding clinical trials, managing the supply of investigational agents, and fostering collaborations between researchers, pharmaceutical companies, and academic institutions. The program aims to improve cancer treatment outcomes through innovative research and drug development.
|Purpose=Boosts cancer treatment development by funding trials, managing agents, and linking researchers, pharma, and academia for innovative outcomes.
|Website=https://ctep.cancer.gov/
|Website=https://ctep.cancer.gov/
|ProgramStart=1971
|ProgramStart=1971